Investing Profile

R. Jacob Vogelstein

InvestorVCFounder
Co-Founder and Managing Partner at Catalio Capital Management
Photo of R. Jacob Vogelstein, Managing Partner at Catalio Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Catalio Capital Managing Partner
$100K - $5.0M
$1.5M
8
CompanyStageDateRound SizeTotal Raised
Clasp Therapeutics
Series AMar 2024$150M
$150M
Co-investors: George C. Petrocheilos (Catalio Capital), Andrea van Elsas (Third Rock Ventures), Jack Nielsen (Vivo Capital)
NextPoint Therapeutics
Series BFeb 2024$43M
$120M
Co-investors: Paulina Hill (Polaris Partners), Detlev Biniszkiewicz (MPM Capital)
Iambic Therapeutics
Series BOct 2023$100M
Series AJul 2021$53M
$200M
Co-investors: Brian Keil (Alumni Ventures ), Kurt von Emster (Abingworth), Naren Gupta (Nexus Venture Partners), Ayman AlAbdallah
Haystack Oncology
Series ANov 2022$56M
$56M
Co-investors: George C. Petrocheilos (Catalio Capital)
Pheast Therapeutics
Series AApr 2022$76M
$76M
Co-investors: George C. Petrocheilos (Catalio Capital), Steven Gillis (ARCH Venture Partners)
Bayesian Health
Series UnknownJul 2021$15M
$15M
Co-investors: Vineeta Agarwala (Andreessen Horowitz), Julie Yoo (Andreessen Horowitz), Vijay Pande (Andreessen Horowitz)
eNeura Therapeutics
Series DFeb 2018$17M
$17M